Article
Evaluating the state of the science for adeno-associated virus integration: An integrated perspective
10 Jun 2022
Abstract excerpt
On August 18, 2021, the American Society of Gene and Cell Therapy (ASGCT) hosted a virtual roundtable on adeno-associated virus (AAV) integration, featuring leading experts in preclinical and clinical AAV gene therapy, to further contextualize and understand this phenomenon. Recombinant AAV (rAAV) vectors are used to develop therapies for many conditions given their ability to transduce multiple cell types,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
